Lorazepam Liquid
Product Images NDC 0121-0770

2 FDA label images from Pai Holdings, Llc Dba Pai Pharma · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 0121-0770). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pai Holdings, Llc Dba Pai Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lorazepam-01 (Lorazepam 1)

Lorazepam-01 (Lorazepam 1)
Chemical structure of lorazepam, showing its molecular arrangement including chlorine atoms and the central benzodiazepine core.*
FDA Label Image

Principal Display Panel (30 mL Bottle Carton)

Principal Display Panel (30 mL Bottle Carton)
Packaging label for Lorazepam Oral Concentrate USP 2 mg/mL liquid in a 30 mL bottle with dropper, labeled by PAI Holdings, LLC dba PAI Pharma. The label includes dosing instructions, storage requirements, and a volume-to-dose chart. The design features a purple accent and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.